Skip to Main Content

6,227

Views

11

CrossRef citations to date

0

Altmetric

Original Research

A cell-engineered system to assess tumor cell sensitivity to CD8⁺ T cell-mediated cytotoxicity

Nadine Nelsona Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, UKView further author information

,

Marta Lopez-Pelaeza Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, UKView further author information

,

Asis Palazonb Oncology, MedImmune Ltd, Cambridge, UKView further author information

,

Edmund Poonb Oncology, MedImmune Ltd, Cambridge, UKView further author information

,

Maike De La Rochec Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UKView further author information

,

Simon Barrya Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, UKView further author information

,

Viia Valge-Archera Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, UKView further author information

,

Robert W. Wilkinsonb Oncology, MedImmune Ltd, Cambridge, UKView further author information

,

Simon J. Dovedib Oncology, MedImmune Ltd, Cambridge, UKCorrespondence[email protected]
View further author information

&

Paul D. Smitha Bioscience, Oncology, IMED Biotech Unit, AstraZeneca, Cambridge, UKCorrespondence[email protected]
View further author information